Profile
| Metric | Value |
|---|---|
| Full Name | Johnson & Johnson |
| Ticker | NYSE: JNJ |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | jnj.com |
| Employees | 138,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $204.39 | |
| Price, 1D Change | -0.66% | |
| Market Cap | $492B | |
| TTM Dividend Yield | 2.51% | |
| PE Ratio | 19.73 | |
| Beta | 0.05 | |
| Revenue | $89B | |
| Revenue, 1Y Change | +4.31% | |
| EPS | $5.79 | |
| EPS, 1Y Change | +4.63% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.30 | |
| Next Ex-Dividend | $1.30 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.79 | |
| EPS Estimate | $10.85 | |
| EPS Est. Change | +87.35% | |
| Revenue | $88.82B | |
| Revenue Estimate | $93.75B | |
| Revenue Est. Change | +5.55% | |
| Current Price | $204.39 | |
| Price Target | - | $212.52 |
| Price Tgt. Change | - | +3.98% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.92 | $5.53 | -44.21% | |
| $9.96 | $5.79 | -41.85% | |
| $10.85 | N/A | +87.35% | |
| $11.52 | N/A | +98.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $84.77B | $85.15B | +0.45% | |
| $88.78B | $88.82B | +0.05% | |
| $93.75B | N/A | +5.55% | |
| $98.59B | N/A | +11.00% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +43.66% | |
| Price, 3Y | +16.41% | |
| Market Cap, 1Y | +43.81% | |
| Market Cap, 3Y | +7.31% | |
| Revenue, 1Y | +4.31% | |
| Revenue, 3Y | -5.27% | |
| EPS, 1Y | +4.63% | |
| EPS, 3Y | -25.84% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $204.39 | |
| SMA 200 | $175.20 | |
| SMA 200 vs Price | -14.28% | |
| SMA 50 | $201.68 | |
| SMA 50 vs Price | -1.33% | |
| Beta | 0.05 | |
| ATR | $3.25 | |
| 14-Day RSI | 47.67 | |
| 10-Day Volatility | 11.79% | |
| 1-Year Volatility | 19.38% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.30 | |
| Upcoming | $1.30 | |
| Dividend Yield | 2.40% | |
| Total Dividend | $4.91 | |
| Dividends Paid | $11.82B | |
| Payout Ratio | 84.05% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $88.82B | |
| EPS | $5.79 | |
| Gross Profit | $60.96B | |
| Gross Margin | 68.63% | |
| Operating Profit | $20.82B | |
| Operating Margin | -7.93% | |
| Net Income | $14.07B | |
| Net Margin | 15.84% | |
| EBITDA | $28.16B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.53 | |
| Current Ratio | 1.11 | |
| Quick Ratio | 0.86 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 4.84 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 19.73 | |
| PS Ratio | 5.34 | |
| PB Ratio | 6.21 | |
| EV/EBITDA | 16.68 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $71.49B | |
| Cash & Equivalents | $24.52B | |
| Total Assets | $180.10B | |
| Current Assets | $55.89B | |
| Total Liabilities | $108.61B | |
| Current Liabilities | $50.32B | |
| Total Debt | $37.83B | |
| Short Term Debt | $5.98B | |
| Accounts Payable | $10.31B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $74.75B | |
| Operating Expenses | $40.13B | |
| Cost Of Goods Sold | $27.86B | |
| SG&A | $0.00 | |
| D&A | $7.34B | |
| Interest Expense | $0.00 | |
| Income Tax | $2.62B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $24.27B | |
| CFI | -$18.60B | |
| CFF | -$3.13B | |
| Capex | $4.42B | |
| Free Cash Flow | $19.84B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Goldman Sachs | → | |
| B of A Securities | → | |
| Morgan Stanley | → | |
| RBC Capital | → | |
| Citigroup | → | |
| Guggenheim | → | |
| Barclays | → | |
| Freedom Capital Markets | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
Screeners with JNJ
Data Sources & References
- JNJ Official Website www.jnj.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of Dow Jones Industrial Average Companies en.wikipedia.org/wiki/Dow_Jones_Industrial_Average
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj
FAQ
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is NYSE:JNJ
Does Johnson & Johnson pay dividends?
Yes, Johnson & Johnson pays dividends. The last payment was $1.30, with an ex-dividend date on November 25, 2025
What sector is Johnson & Johnson in?
Johnson & Johnson is in the Healthcare sector
What industry is Johnson & Johnson in?
Johnson & Johnson is in the General Drug Manufacturers industry
What country is Johnson & Johnson based in?
Johnson & Johnson is headquartered in United States
When did Johnson & Johnson go public?
Johnson & Johnson initial public offering (IPO) was on January 2, 1943
Is Johnson & Johnson in the S&P 500?
Yes, Johnson & Johnson is included in the S&P 500 index
Is Johnson & Johnson in the NASDAQ 100?
No, Johnson & Johnson is not included in the NASDAQ 100 index
Is Johnson & Johnson in the Dow Jones?
Yes, Johnson & Johnson is included in the Dow Jones index
When was Johnson & Johnson last earnings report?
Johnson & Johnson's most recent earnings report was on October 14, 2025
When does Johnson & Johnson report earnings?
The next expected earnings date for Johnson & Johnson is January 21, 2026